New Ways of Doing Magnetic Resonance Imaging in Children and Adults

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04643015
Collaborator
(none)
20
1
36
0.6

Study Details

Study Description

Brief Summary

This study is being done to see how we can prevent problems caused by movement during the MRI scan. Different ways of doing the scan (techniques) will be tested to see if they are practical and can prevent problems related to motion. For example, changes in the timing of the magnetic field and the radio waves will be examined, and at changes in the way a computer is used to process the images. The new techniques will be compared with the techniques that are usually used.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: MRI

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
New Image Techniques for Magnetic Resonance Imaging in Children and Adults
Actual Study Start Date :
Nov 18, 2020
Anticipated Primary Completion Date :
Nov 18, 2023
Anticipated Study Completion Date :
Nov 18, 2023

Arms and Interventions

Arm Intervention/Treatment
Study Participants

Patients of any age, including males and females, who are being treated in the Department of Pediatrics and are already scheduled to undergo MRI

Diagnostic Test: MRI
Briefly, new MRI sequences will be used on a patient who is undergoing a scheduled, clinically necessary MRI exam. Any new research sequence will be scanned in addition to the clinically required sequences and will not interfere with the clinical scan other than requiring five to ten minutes of additional "table time". There will be no invasive measures under this protocol.

Outcome Measures

Primary Outcome Measures

  1. Compare Image Quality [Day of MRI]

    To assess the new MRI sequences or MRI analysis methods and compare their image quality to current clinical ones. Specifically, we aim to compare the routine sequences with the experimental sequences.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of any age, including males and females, who are being treated in the Department of Pediatrics and are already scheduled to undergo MRI
Exclusion Criteria:
  • Anyone who would normally be excluded from undergoing an MRI examination as per Memorial Hospital for Cancer and Allied Diseases Screening Questionnaire for MRI (Appendix A). Subjects with pacemakers or aneurysm clips that are MRI conditional or MRI compatible may enroll in the study if the study is clinically indicated.

  • Female patients who are pregnant

  • Patients who are unable to comply or complete the MRI exam due to claustrophobia or high levels of anxiety

  • Patients at higher risk due to age, frailty, or the emergent nature of their condition

  • Patients who are undergoing MRI only of the head, neck or spine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memorial Sloan Kettering Cancer Center New York New York United States 10065

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Gerald Behr, MD, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT04643015
Other Study ID Numbers:
  • 20-482
First Posted:
Nov 24, 2020
Last Update Posted:
Feb 11, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Memorial Sloan Kettering Cancer Center

Study Results

No Results Posted as of Feb 11, 2022